Catechol-O-methyltransferase is dispensable for vascular protection by estradiol in mouse models of atherosclerosis and neointima formation.
Estradiol is converted to the biologically active metabolite 2-methoxyestradiol via the activity of the enzyme catechol-O-methyltransferase (COMT). Exogenous administration of both estradiol and 2-methoxyestradiol reduces experimental atherosclerosis and neointima formation, and COMT-dependent formation of 2-methoxyestradiol likely mediates the antimitogenic effect of estradiol on smooth muscle cells in vitro. This study evaluated whether 2-methoxyestradiol mediates the vasculoprotective actions of estradiol in vivo. Wild-type (WT) and COMT knockout (COMTKO) mice on an apolipoprotein E-deficient background were gonadectomized and treated with estradiol or placebo. Exogenous estradiol reduced atherosclerotic lesion formation in both females (WT, -78%; COMTKO, -82%) and males (WT, -48%; COMTKO, -53%) and was equally effective in both genotypes. We further evaluated how exogenous estradiol affected neointima formation after ligation of the carotid artery in ovariectomized female mice; estradiol reduced intimal hyperplasia to a similar extent in both WT (-80%) and COMTKO (-77%) mice. In ovarian-intact female COMTKO mice, atherosclerosis was decreased (-25%) compared with WT controls. In conclusion, the COMT enzyme is dispensable for vascular protection by exogenous estradiol in experimental atherosclerosis and neointima formation in vivo. Instead, COMT deficiency in virgin female mice with intact endogenous production of estradiol results in relative protection against atherosclerosis.
Wallenberg Laboratory for Cardiovascular Research, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Bruna Stråket 16, SE-413 45 Gothenburg, Sweden.
Anna S
AS
Wilhelmson
Johan
J
Bourghardt-Fagman
Joseph A
JA
Gogos
Per
P
Fogelstrand
Asa
A
Tivesten
D000077584:2-Methoxyestradiol; D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy*; D001808:Blood Vessels / Q000187:drug effects; D002394:Catechol O-Methyltransferase / Q000502:physiology*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D008297:Male; D051379:Mice; D058426:Neointima / Q000188:drug therapy*; D020011:Protective Agents
D020011:Protective Agents; D004958:Estradiol; D000077584:2-Methoxyestradiol; D002394:Catechol O-Methyltransferase